FDA Launches Internal AI Tool "Elsa" to Streamline Regulatory and Scientific Workflows
The U.S. Food and Drug Administration has deployed Elsa, an internal generative AI tool designed to assist employees with tasks …
All Posts
Sarepta Secures First FDA Platform Designation for Gene Therapy Delivery Technology
The U.S. FDA has granted Platform Technology Designation to Sarepta Therapeutics’ rAAVrh74 viral vector, the delivery component used in SRP-9003, …
ImmunoPrecise AI Discovers Pan-Serotype Dengue Vaccine Target Fully In Silico
ImmunoPrecise Antibodies Ltd. (IPA) reported an in silico discovery of a single, strictly conserved epitope across all four dengue virus …
Antheia Raises $56M Series C to Scale Biosynthetic Drug Ingredient Production, Expands to Asia
Menlo Park–based biomanufacturing company Antheia, founded in 2015 by Dr. Christina Smolke and Dr. Kristy Hawkins, announced a $56 million …
AI-Designed Drug Reaches Clinical Validation: Insilico’s Rentosertib in Nature Medicine
Today, Nature Medicine published peer-reviewed Phase IIa clinical results for Rentosertib (ISM001-055), a TNIK inhibitor developed by Insilico Medicine using a …
French Startup Using AI and Click Chemistry to Speed Up Microbial Detection Raises €5M
Diamidex, a Marseille-based company developing microbiological testing tools for industrial and environmental labs, has expanded the international reach of its …
AI-Based Next-Generation-Phenotyping for Rare Disease Diagnosis
Rare diseases, which affect more than 300 million people worldwide, are often difficult to diagnose. Many patients wait five years …
BioAge Preps Brain-Penetrant NLRP3 Inhibitor for Obesity IND
BioAge Labs has finished the pre-clinical package for BGE-102, an orally available, brain-penetrant NLRP3 inhibitor that the company is advancing …
Insilico Medicine's AI Designs ENPP1 Inhibitor for Immune Modulation in Cancer
A study published in Nature Communications reports the development of ISM5939, an orally active small-molecule ENPP1 inhibitor designed using Insilico …
Medable Launches Digital Long-Term Follow-Up Model for Cell and Gene Therapy Trials
Medable, a U.S.-based provider of software infrastructure for decentralized clinical trials, has introduced a digital-first Long-Term Follow-Up (LTFU) model intended …
Finnish CurifyLabs Raises €6.7M to Replace Manual Compounding With Robotic Drug Manufacturing
CurifyLabs, a Finnish healthtech company, has raised €6.7 million to expand its automated solution for manufacturing compounded medications. The round was …
Biostate AI Raises $12M to Build RNA-Based Foundation Model for Molecular Diagnostics
Biostate AI has raised $12 million in Series A funding to scale its RNA sequencing platform and train a general-purpose …